Skip to main navigation Skip to search Skip to main content

π-HuB: the proteomic navigator of the human body

  • The π-HuB Consortium
  • National Center for Protein Sciences (Beijing)
  • International Academy of Phronesis Medicine (Guangdong)
  • Swiss Federal Institute of Technology Zurich
  • Macquarie University
  • Third Military Medical University
  • Academy of Military Medical Science China
  • Johns Hopkins University
  • CAS - Center for Excellence in Molecular Cell Science
  • General Hospital of People's Liberation Army
  • Academia Sinica - Institute of Chemistry
  • Peking University
  • Queen's University Belfast
  • Centro Nacional de Biotecnología-CSIC
  • Max Planck Institute of Biochemistry
  • AI for Science Institute
  • Cedars-Sinai Medical Center
  • Fudan University
  • Hudson Institute of Medical Research
  • Monash University
  • University of Ottawa
  • Zhejiang University
  • Pengcheng Laboratory
  • University of British Columbia
  • The University of Tokyo
  • University of California at Los Angeles
  • Wuhan University
  • Lee Kong Chian School of Medicine
  • Southern University of Science and Technology
  • Tianjin Institute of Environmental and Operational Medicine
  • Westlake University
  • Westlake Laboratory of Life Sciences and Biomedicine
  • Utrecht University
  • Netherlands Proteomics Center
  • European Molecular Biology Laboratory
  • Salk Institute for Biological Studies
  • National Cancer Centre
  • Amsterdam UMC
  • University of Galway
  • Northwestern University
  • University of Waterloo
  • Central China Institute of Artificial Intelligence
  • National University of Singapore
  • CAS - Institute of Microbiology
  • Leibniz-Forschungsinstitut für MolekularePharmakologie (FMP)
  • CAS - Institute of Zoology
  • Yale University
  • Chinese Academy of Medical Sciences
  • Universiti Kebangsaan Malaysia
  • Central South University
  • Tsinghua University
  • Institute for Systems Biology
  • BGI-Shenzhen
  • Shanghai Jiao Tong University
  • Key Laboratory for Endocrine and Metabolic Diseases of the National Health Commission of the PR China
  • University of Michigan, Ann Arbor
  • Yonsei University
  • Universidade de São Paulo
  • Beijing Institute for Stem Cell and Regenerative Medicine
  • University of Chinese Academy of Sciences
  • Irset
  • University of Macau
  • The University of Sydney
  • Magna Græcia University
  • Harvard University
  • Broad Institute
  • Nanjing Medical University
  • Sun Yat-Sen University
  • Indian Institute of Technology Bombay
  • Brock University
  • China-Japan Friendship Hospital
  • University of Zurich
  • Technical University of Munich
  • Centro de Investigacion y de Estudios Avanzados del Instituto Politécnico Nacional
  • Guangzhou Laboratory
  • Guangzhou Medical College
  • Scripps Research Institute
  • China Science and Technology Exchange Center
  • CAS - Shanghai Institute of Nutrition and Health
  • Baylor College of Medicine
  • CAS - Dalian Institute of Chemical Physics
  • Changping Laboratory
  • The First Affiliated Hospital of Guanzhou Medical University
  • CAS - Guangzhou Institute of Biomedicine and Health
  • CAS - Institute of Atmospheric Physics
  • CAS - Academy of Mathematics and System Sciences
  • Xijing Hospital
  • Sun Yat-Sen University Cancer Center
  • Jinan University
  • The Chinese University of Hong Kong, Shenzhen
  • CAS - Shanghai Institute of Materia Medica
  • Naval Medical University
  • Shanghai University of Traditional Chinese Medicine
  • Tsinghua University
  • The University of Osaka
  • Sichuan University
  • Nanfang Hospital

Research output: Contribution to journalArticlepeer-review

29 Scopus citations

Abstract

The human body contains trillions of cells, classified into specific cell types, with diverse morphologies and functions. In addition, cells of the same type can assume different states within an individual’s body during their lifetime. Understanding the complexities of the proteome in the context of a human organism and its many potential states is a necessary requirement to understanding human biology, but these complexities can neither be predicted from the genome, nor have they been systematically measurable with available technologies. Recent advances in proteomic technology and computational sciences now provide opportunities to investigate the intricate biology of the human body at unprecedented resolution and scale. Here we introduce a big-science endeavour called π-HuB (proteomic navigator of the human body). The aim of the π-HuB project is to (1) generate and harness multimodality proteomic datasets to enhance our understanding of human biology; (2) facilitate disease risk assessment and diagnosis; (3) uncover new drug targets; (4) optimize appropriate therapeutic strategies; and (5) enable intelligent healthcare, thereby ushering in a new era of proteomics-driven phronesis medicine. This ambitious mission will be implemented by an international collaborative force of multidisciplinary research teams worldwide across academic, industrial and government sectors.

Original languageEnglish
Pages (from-to)322-331
Number of pages10
JournalNature
Volume636
Issue number8042
DOIs
StatePublished - 12 Dec 2024
Externally publishedYes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Fingerprint

Dive into the research topics of 'π-HuB: the proteomic navigator of the human body'. Together they form a unique fingerprint.

Cite this